The Institutional Biosafety Committee is co-chaired by Dr. Dr. Shanmugam Nagarajan and Dr. Meghan Blackledge and reviews the use of any activities involving recombinant DNA, Select Agents, biotoxins, infectious agents, blood-borne pathogens, or nano particles. All requests to work with these items must be submitted to the IBC for review and approval. All submissions are made via Cayuse and any changes to proposed use of these materials must be submitted to the IBC through Cayuse as well.
If you have any questions or concerns regarding the use of recombinant DNA, Select Agents, biotoxins, infectious agents, blood-borne pathogens, or nano particles, please contact the IBC Chair via email at [email protected] or call RASP at 336-841-9313.
Federal Regulations
More information regarding the use of these materials is available from federal agencies such as the NIH and the CDC.